Posts

Japan Approves Anti-CD19 Monoclonal Antibody UPLIZNA for Suppression of Relapse in Immunoglobulin G4-Related Disease (IgG4-RD)

on

MediKarma Scales Its Clinical And Commercial Acumen With Appointment Of Dr. Scott Howell As Chief Clinical Officer And Angela Breton As Chief Revenue Officer

on

Roche Bags EU Nod for SC Formulation of Lunsumio, Re-Igniting Bispecific Battle with Tepkinly

on

Alkermes Ups Bid for Avadel Amid Lundbeck’s Competing Offer in Narcolepsy Drug Takeover Battle

on

US-Backed Group Reports Success with New Tuberculosis Treatment in Phase 2 Study

on

FDA Pushes for Onshoring and Improved Data Fidelity in Generic Drug User Fee (GDUFA IV) Negotiations

on

Nxera Pharma to Cut 15% of Workforce in Japan and UK as Part of Restructuring Plan

on

Spotlight On: Big Pharma's Big Bets on In Vivo Cell Therapy

on

Zymeworks Pivots to Royalty-Driven Model After Strong Ziihera Data in Gastric Cancer

on

Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors

on

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA

on

Roche's Oral SERD Giredestrant Delays Early Breast Cancer Recurrence in Late-Stage Trial

on

Merck Continues Cuts: 204 Employees Laid Off in New Jersey

on